Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹-1,245 Cr₹-1,066 Cr₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-1,245 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹-1,245 Cr
Mar2025₹-1,066 Cr
Mar2024₹-1,049 Cr
Mar2023₹-1,805 Cr
Mar2022₹-1,655 Cr

How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹-1,245 Cr
Negative
Mar2025 ₹-1,066 Cr
Negative
Mar2024 ₹-1,049 Cr
Negative
Mar2023 ₹-1,805 Cr
Negative
Mar2022 ₹-1,655 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹73,761.4 Cr -2.3% 17.5% 42.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,688.0 Cr -1.4% 6.3% 7.8% Stock Analytics
DIVIS LABORATORIES ₹295,080.0 Cr -1.8% 20.6% 70.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,677.0 Cr -1.9% 2.4% 22.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,852.0 Cr 0.8% 12.6% 12.3% Stock Analytics
CIPLA ₹111,731.0 Cr -2.4% 4.4% -8.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.3%

17.5%

42.3%

SENSEX

1.8%

11.1%

-1.6%


You may also like the below Video Courses